- Home
- THAR vs IBG Comparison
THAR vs IBG Comparison
Compare THAR & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- IBG
- Stock Information
- Founded
- THAR 2017
- IBG 2018
- Country
- THAR United States
- IBG Australia
- Employees
- THAR N/A
- IBG N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- THAR Health Care
- IBG Consumer Staples
- Exchange
- THAR Nasdaq
- IBG Nasdaq
- Market Cap
- THAR 5.5M
- IBG 5.4M
- IPO Year
- THAR 2022
- IBG 2024
- Fundamental
- Price
- THAR $1.35
- IBG $0.64
- Analyst Decision
- THAR Strong Buy
- IBG Strong Buy
- Analyst Count
- THAR 1
- IBG 1
- Target Price
- THAR $17.00
- IBG N/A
- AVG Volume (30 Days)
- THAR 119.3K
- IBG 680.2K
- Earning Date
- THAR 08-14-2025
- IBG 08-26-2025
- Dividend Yield
- THAR N/A
- IBG N/A
- EPS Growth
- THAR N/A
- IBG N/A
- EPS
- THAR N/A
- IBG N/A
- Revenue
- THAR N/A
- IBG $2,931,243.00
- Revenue This Year
- THAR N/A
- IBG N/A
- Revenue Next Year
- THAR N/A
- IBG N/A
- P/E Ratio
- THAR N/A
- IBG N/A
- Revenue Growth
- THAR N/A
- IBG N/A
- 52 Week Low
- THAR $0.95
- IBG $0.44
- 52 Week High
- THAR $6.39
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- THAR 46.35
- IBG N/A
- Support Level
- THAR $1.15
- IBG N/A
- Resistance Level
- THAR $1.66
- IBG N/A
- Average True Range (ATR)
- THAR 0.12
- IBG 0.00
- MACD
- THAR 0.01
- IBG 0.00
- Stochastic Oscillator
- THAR 39.22
- IBG 0.00
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.